Prevalence and association of depression with uremia in dialysis population: a retrospective cohort analysis
Authors:
Open Access
- 12 June 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (24) , e20401
Abstract
Depression may hamper the immune system and nutritional status, which leads to poor outcomes of treatment. It is very common in dialysis patients. There are the numbers of parameters affected by the depression of patients and available studies are not enough to define the association between biological parameters and depression in the dialysis population. The purposes of the study were to find the prevalence of depression and association of it with the biochemical abnormalities in the dialysis patients. The selected battery of tests (clinician-administered questionnaires) were applied to dialysis patients (test cohort, n = 298) and caregivers (control cohort, n = 202) for establishing depression. The demographic and clinical conditions of participants were also collected. Univariate analysis followed by multiple regression analysis was performed for demographical parameters, clinical conditions, and laboratory results for the detection of association of them with depression. The abnormal test considered as more than 2 SD of mean below the normal value. Out of all tests, at least 2 abnormal tests were considered as mild depression. More than half of abnormal parameters among all tests were considered as moderate depression and all abnormal parameters were considered as severe depression. There was a significant difference for all the test between dialysis patients and the caregivers (P < .0001 for all). The half (153 out of 298) of dialysis patients were depressive and clinically asymptomatic. 70 (23%) dialysis patients were mild depressive, 45 (15%) dialysis patients were moderate depressive, and 38 (13%) dialysis patients were severely depressive. Serum phosphate (P = .023), level of parathyroid hormone (P = .021), and urea reduction rate (P = .048) were directly associated with depression. Biochemical abnormalities (serum phosphate level, parathyroid hormone, and urea reduction rate) were independent predictors of depression in the dialysis population. Level of evidence: III.Keywords
This publication has 24 references indexed in Scilit:
- Nonadherence in Dialysis Patients: Prevalence, Measurement, Outcome, and Psychological DeterminantsSeminars in Dialysis, 2013
- Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studiesKidney International, 2013
- Prevalence and correlates of depression among chronic kidney disease patients in TaiwanBMC Nephrology, 2013
- Association of Depression and Antidepressant Use with Mortality in a Large Cohort of Patients with Nondialysis-Dependent CKDClinical Journal of the American Society of Nephrology, 2012
- Goal-Oriented Patient Care — An Alternative Health Outcomes ParadigmNew England Journal of Medicine, 2012
- A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal diseaseKidney International, 2012
- DEPRESSIVE SYMPTOMS AND DIETARY ADHERENCE IN PATIENTS WITH END‐STAGE RENAL DISEASEJournal of Renal Care, 2011
- Depressive symptoms and chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2006International Urology and Nephrology, 2010
- No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adultsBritish Journal of Nutrition, 2010
- Prevalence of Major Depressive Episode in CKDAmerican Journal of Kidney Diseases, 2009